Welcome to ARVO Insight

In this issue

Burgoyne begins term as ARVO president

Claude BurgoyneClaude F. Burgoyne, MD, FARVO, of Devers Eye Institute is the new president of ARVO. He succeeds Emily Chew, MD, FARVO, (National Eye Institute, National Institutes of Health) whose one-year term ended in May following the ARVO Annual Meeting.

Burgoyne, a glaucoma clinician and surgeon, is senior scientist, Van Buskirk Chair for Ophthalmic Research and director of the Optic Nerve Head Research Laboratory at Devers Eye Institute. He also serves as clinical professor of ophthalmology at Oregon Health and Sciences University. He has been an ARVO member in the Glaucoma (GL) Section since 1991 and has served on the GL Section of the Annual Meeting Program Committee, the IOVS editorial board and the Board of Trustees.

Coupland awarded ICO Ophthalmic Pathology Award

CouplandThe International Council of Ophthalmology will present ARVO Vice President Sarah Coupland, MBBS, PhD, FRCPath, FARVO, with the ICO Ophthalmology Ophthalmic Pathology Award during the opening ceremony at the 2018 World Ophthalmology Congress® (WOC), June 16 – 19, in Barcelona.

The ICO Ophthalmic Pathology Award is presented every four years to individuals who have been nominated by their peers and selected by the ICO. Coupland is the first U.K. resident and second woman to receive the award. She will present the Naumann Lecture at WOC.


EverSight-April 30